Abstract
Since the first recognitions by governments of the pandemic characteristic of the SARS-CoV-2 infections, public health agencies have warned the public about the dangers of the virus to persons with a variety of underlying physical conditions, many of which are more commonly found in persons over 50 years old or in certain ethnic groups. To investigate the statistical, rather than physiological basis of such warnings, this study examines correlations globally on a nation-by-nation basis between the statistical data concerning COVID-19 fatalities among the populations of the ninety-nine countries with the greatest number of SARS-CoV-2 infections plus the statistics of potential co-morbidities that may influence the severity of the infections. It examines reasons that may underlie of the degree to which advanced age increases the risk of mortality of an infection and contrasts the risk factors of SARS-Cov-2 infections with those of influenzas and their associated pneumonias.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is completely self-supported without any outside funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All data are in the public domain
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data relevant to SARS-CoV-2 are revised to include all of 2020. Regional variations are analyzed and and are now reported. Time-variation of case fatality rate has been examined.
Data Availability
All data in this article are in the public domain
